We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity.

Cancer cell | Mar 18, 2013

Understanding the mechanism underlying the regulation of the androgen receptor (AR), a central player in the development of castration-resistant prostate cancer (CRPC), holds promise for overcoming the challenge of treating CRPC. We demonstrate that the ubiquitin ligase Siah2 targets a select pool of NCOR1-bound, transcriptionally-inactive AR for ubiquitin-dependent degradation, thereby promoting expression of select AR target genes implicated in lipid metabolism, cell motility, and proliferation. Siah2 is required for prostate cancer cell growth under androgen-deprivation conditions in vitro and in vivo, and Siah2 inhibition promotes prostate cancer regression upon castration. Notably, Siah2 expression is markedly increased in human CRPCs. Collectively, we find that selective regulation of AR transcriptional activity by the ubiquitin ligase Siah2 is important for CRPC development.

Pubmed ID: 23518348 RIS Download

Mesh terms: Animals | Castration | Cell Line, Tumor | Cell Movement | Cell Proliferation | Gene Expression Regulation, Neoplastic | Humans | Lipid Metabolism | Male | Mice | Nuclear Proteins | Nuclear Receptor Co-Repressor 1 | Prostatic Neoplasms | RNA Interference | RNA, Small Interfering | Receptors, Androgen | Signal Transduction | Transcription, Genetic | Ubiquitin | Ubiquitin-Protein Ligases

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

Associated grants

  • Agency: Wellcome Trust, Id: 090532/Z/09/Z
  • Agency: NCI NIH HHS, Id: R00 CA154888
  • Agency: NCI NIH HHS, Id: CA111515
  • Agency: NCI NIH HHS, Id: R01 CA111515
  • Agency: Canadian Institutes of Health Research, Id: CA154888
  • Agency: NCI NIH HHS, Id: K99 CA154888
  • Agency: NCI NIH HHS, Id: R01 CA108646
  • Agency: NCI NIH HHS, Id:

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.